91 related articles for article (PubMed ID: 17591146)
1. Metoclopramide also acts at serotonin receptors.
Murphy E
Anaesth Intensive Care; 2007 Jun; 35(3):447. PubMed ID: 17591146
[No Abstract] [Full Text] [Related]
2. 5HT3-antagonist receptors: their role in drug-induced emesis.
Dieras V; Extra JM; Le Bonniec M; Madelaine I; Espie M; Marty M
Nouv Rev Fr Hematol (1978); 1990; 32(6):449-52. PubMed ID: 1983228
[TBL] [Abstract][Full Text] [Related]
3. From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists.
Sanger GJ; King FD
Drug Des Deliv; 1988 Dec; 3(4):273-95. PubMed ID: 3076395
[TBL] [Abstract][Full Text] [Related]
4. Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors.
Hamik A; Peroutka SJ
Cancer Chemother Pharmacol; 1989; 24(5):307-10. PubMed ID: 2527092
[TBL] [Abstract][Full Text] [Related]
5. [Value of 5-HT3 receptor antagonists, particularly as anti-emetic drugs].
Lechat P
Ann Pharm Fr; 1991; 49(6):307-16. PubMed ID: 1842169
[TBL] [Abstract][Full Text] [Related]
6. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
Tsukagoshi S; Ohta J; Taguchi T
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
[TBL] [Abstract][Full Text] [Related]
7. [Type-3 serotonin receptor blockaders (5-HT3)--a new class of antiemetic preparations].
Legeza VI
Eksp Klin Farmakol; 1994; 57(4):72-5. PubMed ID: 7950795
[No Abstract] [Full Text] [Related]
8. The 5-hydroxytryptamine receptor antagonists as antiemetics: preclinical evaluation and mechanism of action.
Andrews PL; Bhandari P
Eur J Cancer; 1993; 29A Suppl 1():S11-6. PubMed ID: 8427719
[No Abstract] [Full Text] [Related]
9. Effects of enhancement and antagonism of 5-hydroxytryptamine activity on metoclopramide-induced aldosterone secretion in man.
Sommers DK; Meyer EC; van Wyk M
Res Exp Med (Berl); 1991; 191(6):423-7. PubMed ID: 1775733
[TBL] [Abstract][Full Text] [Related]
10. Basic mechanisms of antimigraine drugs.
Fozard JR
Adv Neurol; 1982; 33():295-307. PubMed ID: 7034488
[No Abstract] [Full Text] [Related]
11. Muscle relaxants and 5-HT(3) receptors.
Gyermek L
Anesth Analg; 2000 Oct; 91(4):1039. PubMed ID: 11004075
[No Abstract] [Full Text] [Related]
12. Gastrointestinal prokinetic activity of serotonergic agents.
VanSyoc ML; Wong AG; Perry MR; Smith WL
Proc West Pharmacol Soc; 1992; 35():117-21. PubMed ID: 1502210
[No Abstract] [Full Text] [Related]
13. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
Gullikson GW; Loeffler RF; Viriña MA
J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
[TBL] [Abstract][Full Text] [Related]
15. [An experimental study of the role of a blockade of serotonin 5-HT3 receptors and dopamine D2 receptors in the mechanism of the occurrence of early radiation vomiting in monkeys].
Martirosov KS; Grigor'ev IuG; Zorin VV; Andrianova IE
Radiats Biol Radioecol; 2000; 40(3):277-80. PubMed ID: 10907404
[TBL] [Abstract][Full Text] [Related]
16. Interactions between metoclopramide and morphine: enhanced antinociception and motor dysfunction in rats.
Kamerman PR; Becker N; Fick LG
Clin Exp Pharmacol Physiol; 2007; 34(1-2):106-12. PubMed ID: 17201744
[TBL] [Abstract][Full Text] [Related]
17. [New therapeutic possibilities with drugs affecting serotonin receptors].
Spigset O
Tidsskr Nor Laegeforen; 1992 May; 112(13):1700-4. PubMed ID: 1509427
[TBL] [Abstract][Full Text] [Related]
18. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
Yoshikawa T; Yoshida N; Oka M
Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
[TBL] [Abstract][Full Text] [Related]
19. Metoclopramide.
Schulze-Delrieu K
Gastroenterology; 1979 Oct; 77(4 Pt 1):768-79. PubMed ID: 223940
[No Abstract] [Full Text] [Related]
20. Emerging differences between 5-HT3 receptor antagonists.
Marr HE; Davey PT; Bartlett AJ
Anticancer Drugs; 1991 Dec; 2(6):513-8. PubMed ID: 1806029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
